| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. (ATRA) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $13.97M | - | |
| CEO | 143.1K | $1.51M | - | |
| Other | 52.0K | $549.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2018 | McGrath John | EVP &Chief Financial Officer | Sale+OE | 37,000 | $24.35 | $900,815.00 | -10.9% | |
| Jan 12, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 28,700 | $21.39 | $613,843.00 | -1.5% | |
| Dec 29, 2017 | McGrath John | EVP &Chief Financial Officer | Sell | 32,000 | $20.00 | $640,000.00 | -24.9% | |
| Dec 29, 2017 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 22,200 | $18.29 | $405,958.00 | -1.4% | |
| Dec 13, 2017 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 4,400 | $14.65 | $64,438.00 | -0.5% | |
| Nov 30, 2017 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 4,400 | $14.25 | $62,678.00 | -0.5% | |
| Nov 17, 2017 | Soffer Gad | EVP &Chief Strategy Officer | Sale+OE | 7,000 | $15.00 | $105,000.00 | -2.7% | |
| Nov 16, 2017 | Gallagher Carol Giltner | Director | Sale+OE | 1,184 | $14.20 | $16,812.80 | -1.1% | |
| Nov 16, 2017 | Clark Mitchall G. | EVP &Chief R &Qa Officer | Sale+OE | 3,290 | $14.20 | $46,718.00 | -2.0% | |
| Nov 15, 2017 | Haqq Christopher | EVP, R&D &Chief Scientific Of | Sale+OE | 1,604 | $13.36 | $21,429.44 | -0.5% |